Press Releases
January 27, 2025
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
Dr. Barnes brings more than 25 years of biotech leadership expertise and a proven track record in advancing transformative early-stage therapies